FBXO25 regulates MAPK signaling pathway through inhibition of ERK1/2 phosphorylation

Arch Biochem Biophys. 2017 May 1:621:38-45. doi: 10.1016/j.abb.2017.04.003. Epub 2017 Apr 5.

Abstract

The FBXO25 mediates degradation of ELK-1 and thus inhibits transcriptional activation of immediate early genes (iEG). Here we show that FBXO25 regulates yet another node of this signaling pathway, by decreasing MAPK/ERK activity. We show that induction of FBXO25 reduced ERK1/2 phosphorylation independently of MEK1/2. Accordingly, in HAP1 FBXO25 knockout cells (FBXO25KO), we observed that upon PMA treatment ERK1/2 was more active than in parental cells. An increase in cell proliferation under receptor mediated activation of the ERK signaling pathway in FBXO25KO cells was also observed. Taken together we show that FBXO25 functions as a negative regulator of MAPK signaling though the reduction of ERK1/2 activation.

Keywords: ELK-1; ERK1/2; FBXO25; MEK1/2.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • F-Box Proteins / metabolism*
  • Gene Expression Regulation, Enzymologic / physiology*
  • HEK293 Cells
  • Humans
  • MAP Kinase Signaling System / physiology*
  • Mitogen-Activated Protein Kinase 1 / metabolism*
  • Mitogen-Activated Protein Kinase 3 / metabolism*
  • Nerve Tissue Proteins / metabolism*
  • Phosphorylation

Substances

  • F-Box Proteins
  • FBXO25 protein, human
  • Nerve Tissue Proteins
  • MAPK1 protein, human
  • Mitogen-Activated Protein Kinase 1
  • Mitogen-Activated Protein Kinase 3